Cholesterol-A janus-faced molecule in the central nervous system

Handbook of Neurochemistry and Molecular Neurobiology: Neural Membranes and Transport

Volumn , Issue , 2007, Pages 151-170

  Wood, W G ^a   Igbavboa, U ^a   Eckert, G P ^b   Muller W E ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900915924     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-30380-2_7     Document Type: Chapter

References (178)

1. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, et al. 2004. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167:953-960.
2. Agranoff BW. 1989. Lipids. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Siegel G, Agranoff B, Albers RW, Molinoff P, editors. New York: Raven Press, Ltd. pp. 91-107.
3. Anderson R G W. 1993. Caveolae: Where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 90:10909-10913.
4. Anderson R G W, Jacobson K. 2002. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296:1821-1825.
5. Andersson M, Appelkvist EL, Kristensson K, Dallner G. 1987. Distribution of dolichol and dolichyl phosphate in human brain. J Neurochem 49:685-691.
6. Arismendi-Morillo G, Castellano A. 2005. Tumoral micro-blood vessels and vascular microenvironment in human astrocytic tumors. A transmission electron microscopy study. J Neuro-Oncol 73:211-217.
7. Beffert U, Aumont N, Dea D, Lussier-Cacan S, Davignon J, et al. 1998. b-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons. J Neurochem 70:1458-1466.
8. Björkhem I, Diczfalusy U. 2002. Oxysterols. Arterioscler Thromb Vasc Biol 22:734-742.
9. Blanchette-Mackie EJ, Dwyer NK, Amende LM, Kruth HS, Butler JD, et al. 1988. Type-C Niemann-Pick disease: Low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc Natl Acad Sci USA 85:8022-8026.
10. Bodovitz S, Klein WL. 1996. Cholesterol modulates a-secre-tase cleavage of amyloid precursor protein. J Biol Chem 271:4436-4440.
11. Bogman K, Peyer A-K, Török M, Küsters E, Drewe J. 2001. HMG-CoA reductase inhibitors and P-glycoprotein modulation. Br J Pharmacol 132:1183-1192.
12. Bouillot C, Prochiantz A, Rougon G, Allinquant B. 1996. Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties. J Biol Chem 271:7640-7644.
13. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. 1985. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501-1513.
14. Brown DA, London E. 1998. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111-136.
15. Brown DA, London E. 2000. Structure and function of sphin-golipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221-17224.
16. Bu J, Bruckner SR, Sengoku T, Geddes JW, Estus S. 2003. Glutamate regulates caveolin expression in rat hippocam-pal neurons. J Neurosci Res 72:185-190.
17. Burns M, Duff K. 2002. Cholesterol in Alzheimer's disease and tauopathy. Ann NY Acad Sci 977:367-375.
18. Burns MP, Igbavboa U, Wood WG, Duff K. 2004. Common effects of statins on CNS cholesterol and APP processing. Abstract Viewer/Itinerary Planner, Society for Neuroscience 716. 4.
19. Buttini M, Yu GQ, Shockley K, Huang Y, Jones B, et al. 2002. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid b peptides but not on plaque formation. J Neurosci 22:10539-10548.
20. Cameron PL, Ruffin JW, Bollag R, Rasmussen H, Cameron RS. 1997. Identification of caveolin and caveolin-related proteins in the brain. J Neurosci 17:9520-9535.
21. CDC/NCHS 2003. Cholesterol status among adults in the United States. National Health and Nutrition Examination Survey, CDC/NCHS.
22. Chamberlain LH, Burgoyne RD, Gould GW. 2001. SNARE proteins are highly enriched in lipid rafts in PC12 cells: Implications for the spatial control of exocytosis. Proc Natl Acad Sci USA 98:5619-5624.
23. Chung YM, Bae YS, Lee SY. 2003. Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis. Free Radic Biol Med 34:434-442.
24. Connor J, Schroit AJ. 1990. Aminophospholipid translocation in erythrocytes: Evidence for the involvement of a specific transporter and an endofacial protein. Biochemistry 29:37-43.
25. Cordle A, Landreth G. 2005. 3-hydroxy-3-methylglutaryl-co-enzyme A reductase inhibitors attenuate b-amyloid-induced microglial inflammatory responses. J Neurosci 25:299-307.
26. Crisby M, Rahman S M A, Sylvén C, Winblad B, Schultzberg M. 2004. Effects of high-cholesterol diet on gliosis in apoli-poprotein E knockout mice Implications for Alzheimer's disease and stroke. Neurosci Lett 369:87-92.
27. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, et al. 2004. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA 101:2070-2075.
28. Dam H. 1958. Historical introduction to cholesterol. Chemistry, Biochemistry and Pathology. Cook RP, editor. New York: Academic Press; pp. 1-14.
29. Dekroon RM, Armati PJ. 2003. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes. Neurobiol Dis 8:78-89.
30. Diaz C, Schroit AJ. 1996. Role of translocases in the generation of phosphatidylserine asymmetry. J Membr Biol 151:1-9.
31. Dietschy JM. 1997. Overview of cholesterol and lipoprotein metabolism in the brain, liver and extrahepatic organs. Nutr Metab Cardiovasc Dis 7:162-168.
32. Dietschy JM, Turley SD. 2004. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375-1397.
33. Dougherty RM, Galli C, Ferro-Luzzi A, Iacono JM. 1987. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: A study of normal subjects from, Italy, Finland, and the USA. Am J Clin Nuer 45:443-455.
34. Eckert GP, Igbavboa U, Müller WE, Wood WG. 2003. Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains. Brain Res 962:144-150.
35. Eckert GP, Kirsch C, Müller WE. 2001. Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice. Neuroreport 12:883-887.
36. Edidin M. 2003. The state of lipid rafts: From model membranes to cells. Annu Rev Biophys Biomol Struct 32:257-283.
37. Fagan AM, Holtzman DM. 2000. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-β deposition in vivo. Microsc Res Tech 50:297-304.
38. Fagan AM, Holtzman DM, Munson G, Mathur T, Schneider D, et al. 1999. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-), and human apoE transgenic mice. J Biol Chem 274:30001-30007.
39. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, et al. 2001. Simvastatin strongly reduces levels of Alzheimer's disease p-amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo. Proc Natl Acad Sci USA 98:5856-5861.
40. Fielding CJ, Fielding PE. 2003. Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim Biophys Acta 1610:219-228.
41. Garrigues A, Escargueil AE, Orlowski S. 2002. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane. Proc Natl Acad Sci USA 99:10347-10352.
42. 2 activity. J Biol Chem 279:356-362.
43. Gong JS, Kobayashi M, Hayashi H, Zou K, Sawamura N, et al. 2002. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human apoE3 and apoE4 knockin mice. J Biol Chem 277:29919-29926.
44. Harr SD, Uint L, Hollister R, Hyman BT, Mendez AJ. 1996. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem 66:2429-2435.
45. Hayashi H, Campenot RB, Vance DE, Vance JE. 2004. Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J Biol Chem 279:14009-14015.
46. Hayashi H, Igbavboa U, Hamanaka H, Kobayashi M, Fujita SC, et al. 2002. Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipo-protein E4 knockin mice. Neuroreport 13:383-386.
47. Hayashi H, Mizuno T, Michikawa M, Haass C, Yanagisawa K. 2000. Amyloid precursor protein in unique cholesterol-rich microdomains different from caveolae-like domains. Biochim Biophys Acta 1483:81-90.
48. Heart Protection Study Collaborative Group 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simva-statin in 20536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360:7-22.
49. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. 2003. Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 60:1119-1122.
50. Hering H, Lin CC, Sheng M. 2003. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 23:3262-3271.
51. Heverin M, Meaney S, Lütjohann D, Diczfalusy U, Wahren J, et al. 2005. Crossing the barrier: Net flux of 27-hydroxycho-lesterol into the human brain. J Lipid Res 46:1047-1052.
52. Holstein SA, Hohl RJ. 2004. Isoprenoids: Remarkable diversity of form and function. Lipids 39:293-309.
53. Holtzman DM. 2004. In vivo effects of ApoE and clusterin on amyloid-βmetabolism and neuropathology. J Mol Neurosci 23:247-254.
54. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, et al. 1995. Low-density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA 92:9480-9484.
55. Hooper NM. 1999. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts, and caveo-lae (Review). Mol Mem Biol 16:145-156.
56. Howlands DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, et al. 1998. Modulation of secreted β-amyloid precursor protein and amyloid β peptide in brain by cholesterol. J Biol Chem 273:16576-16582.
57. Huang Y, Weisgraber KH, Mucke L, Mahley RW. 2004. Apoli-poprotein E: Diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci 23:189-204.
58. Igbavboa U, Avdulov NA, Chochina SV, Wood WG. 1997. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipopro-tein E, or both proteins. J Neurochem 69:1661-1667.
59. Igbavboa U, Avdulov NA, Schroeder F, Wood WG. 1996. Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J Neurochem 66:1717-1725.
60. Igbavboa U, Eckert GP, Malo TM, Studniski A, Johnson L N A, et al. 2005. Murine synaptosomal lipid raft protein and lipid composition are altered by expression of human apoE3 and 4 and by increasing age. J Neurol Sci 229-230:225-232.
61. Igbavboa U, Hamilton J, Kim H-Y, Sun GY, Wood WG. 2002. A new role for apolipoprotein E: Modulating transport of polyunsaturated phospholipid molecular species in synap-tic plasma membranes. J Neurochem 80:255-261.
62. 1-42. J Biol Chem 278:17150-17157.
63. Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW. 2004. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease. Neurosci Lett 367:228-231.
64. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. 2000. Statins and the risk of dementia. Lancet 356:1627-1631.
65. Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, et al. 2005. Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther 312:786-793.
66. Jordán J, Galindo MF, Miller RJ, Reardon CA, Getz GS, et al. 1998. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocam-pal pyramidal neuronal cultures. J Neurosci 18:195-204.
67. Kabara JJ. 1973. A critical review of brain cholesterol metabolism. Prog Brain Res 40:363-382.
68. Kirsch C, Eckert GP, Müller WE. 2003. Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol 65:843-856.
69. Koch S, Donarski N, Goetze K, Kreckel M, Stuerenburg H-J, et al. 2001. Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res 42:1143-1151.
70. La Du MJ, Shah JA, Reardon CA, Getz GS, Bu G, et al. 2000. Apolipoprotein E receptors mediate the effects of β-amyloid on astrocyte cultures. J Biol Chem 275:33974-33980.
71. La Du MJ, Shah JA, Reardon CA, Getz GS, Bu G, et al. 2001. Apolipoprotein E and apolipoprotein E receptors modulate Aβ-induced glial neuroinflammatory responses. Neurochem Int 39:427-434.
72. Lai EC. 2003. Lipid rafts make for slippery platforms. J Cell Biol 162:365-370.
73. Lee S-J, Liyanage U, Bickel PE, Xia W, Lansbury PT, et al. 1998. A detergent-insoluble membrane compartment contains amyloid-β in vivo. Nat Med 4:730-734.
74. Lichtenberg D, Goñi FM, Heerklotz H. 2005. Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem Sci 30:430-436.
75. Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. 1994. Caveo-lae, caveolin, and caveolin-rich membrane domains: A signaling hypothesis. Trends Cell Biol 4:231-235.
76. Liu Y, Peterson DA, Schubert D. 1998. Amyloid-β peptide alters intracellular vesicle trafficking and cholesterol ho-meostasis. Proc Natl Acad Sci USA 95:13266-13271.
77. Lund EG, Guileyardo JM, Russell DW. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol ho-meostasis in the brain. Proc Natl Acad Sci USA 96:7238-7243.
78. Lutjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, et al. 1996. Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 93:9799-9804.
79. Lütjohann D, Stroick M, Bertsch T, Kühl S, Lindenthal B, et al. 2004. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids 69:431-438.
80. Ma J, Brewer H, Potter H. 1996. Alzheimer Aβ neurotoxicity: Promotion by anti-chymotrypsin, apoE4; inhibition by Aβ-related peptides. Neurobiol Aging 17:773-780.
81. Mahley RW. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
82. Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. 1984. Plasma lipoproteins: Apolipoprotein structure and function. J Lipid Res 25:1277-1294.
83. Maltese WA. 1984. Cholesterol synthesis in cultured skin fibroblasts from patients with Huntington's disease. Biochem Med 32:144-150.
84. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, et al. 1995. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 136:107-122.
85. Masliah E, Mallory M, Veinbergs I, Miller A, Samuel W. 1996. Alternations in apolipoprotein E expression during aging and neurodegeneration. Prog Neurobiol 50:493-503.
86. Mauch DH, Nägler K, Schumacher S, Göritz C, Müller E-C, et al. 2001. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354-1357.
87. Mcfarlane SI, Muniyappa R, Francisco R, Sowers JR. 2002. Pleiotropic effects of statins: Lipid reduction and beyond. J Clin Endocrinol Metab 87:1451-1458.
88. Michikawa M. 2003. The role of cholesterol in pathogenesis of Alzheimer's disease: Dual metabolic interaction between amyloid β-protein and cholesterol. Mol Neurobiol 27:1-12.
89. Mielke MM, Zandi PP, Sjögren M, Gustafson D, Östling S, et al. 2005. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64:1689-1695.
90. Mitter D, Reisinger C, Hinz B, Hollmann S, Yelamanchili SV, et al. 2003. The synaptophysin/synaptobrevin interaction critically depends on the cholesterol content. J Neurochem 84:35-42.
91. Miyata M, Smith JD. 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat Genet 14:55-61.
92. Moore SA, Yoder E, Murphy S, Dutton GR, Spector AA. 1991. Astrocytes not neurons produce docosahexaenoic acid 22:6-ω-3 and arachidonic acid 20:4-ω6. J Neurochem 56:518-524.
93. Morishima-Kawashima M, Ihara Y. 1998. The presence of amyloid β-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry 37:15247-15253.
94. Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A. 1997. Characterization of detergent-insoluble complexes containing the cellular prion protein and scrapie isoform. J Biol Chem 272:6324-6331.
95. Nathan BP, Jiang Y, Wong GK, Shen F, Brewer GJ, et al. 2002. Apolipoprotein E4 inhibits and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res 928:96-105.
96. Ng Ying Kin NM, Palo J, Haltia M, Wolfe LS. 1983. High levels of brain dolichols in neuronal ceroid-lipofuscinosis and senescence. J Neurochem 40:1465-1473.
97. Nishiyama K, Trapp BD, Ikezu T, Ransohoff RM, Tomita T, et al. 1999. Caveolin-3 upregulation activates β-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease. J Neurosci 19:6538-6548.
98. North P, Fleischer S. 1983. Alteration of synaptic membrane cholesterol/phospholipid ratio using a lipid transfer protein. J Biol Chem 258(2):1242-1253.
99. Norton WT, Igbal K, Tiffany C, Tellez-Nagel I. 1978. Hun-tington disease: Normal lipid composition of purified neu-ronal perikarya and whole cortex. Neurology 28:812-816.
100. Oda T, Pasinetti GM, Osterburg HH, Anderson C, Johnson S A FCE. 1994. Purification and characterization of brain clusterin. Biochem Biophys Res Commun 204:1131-1136.
101. Ohyama Y, Meaney S, Heverin M, Ekström L, Brafman A, et al. 2006. Studies on the transcriptional regulation of cholesterol24-hydroxylase (9CYP46A1): Marked insensitiv-ity towards different regulatory axes. J Biol Chem 281:3810-3820.
102. Op den Kamp J A F. 1979. Lipid asymmetry in membranes. Annu Rev Biochem 48:47-71.
103. Palade GE. 1953. Fine structure of blood capillaries. J Appl Phys 24:1424-1436.
104. Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, et al. 2005. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry 66:940-947.
105. Pappolla MA, Bryant-Thomas T, Herbert D, Pacheco J, Fabra Garcia M, et al. 2003. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61:199-205.
106. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. 1987a. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917:148-161.
107. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. 1987b. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospi-nal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain. J Biol Chem 262:14352-14360.
108. Poirier J. 1994. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 17:525-530.
109. Poirier J. 2005. Apolipoprotein E, cholesterol transport, and synthesis in sporadic Alzheimer's disease. J Mol Neurosci 26:355-361.
110. Poirier J, Baccichet A, Dea D, Gauthier S. 1993a. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55:81-90.
111. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, et al. 1993b. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699.
112. Porn MI, Tenhunen J, Slotte JP. 1991. Increased steroid hormone secretion in mouse Leydig tumor cells after induction of cholesterol translocation by sphingomyelin degradation. Biochim Biophys Acta 1093:7-12.
113. Porter FD. 2002. Malformation syndromes due to inborn errors of cholesterol synthesis. J Clin Invest 110:715-724.
114. Puglielli L, Tanzi RE, Kovacs DM. 2003. Alzheimer's disease: The cholesterol connection. Nat Neurosci 6:345-351.
115. Pullarkat RK, Reha H. 1982. Accumulation of dolichols in brains of elderly. J Biol Chem 257:5991-5993.
116. Puttfarcken PS, Manelli AM, Falduto MT, Getz GS, La Du MJ. 1997. Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hip-pocampal cultures. J Neurochem 68:760-769.
117. Quarles RH, Morell P, McFarlin DE. 1989. Diseases involving myelin. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Siegel G, Agranoff B, Albers RW, Molinoff P, editors. New York: Raven Press; pp. 697-713.
118. Quest A F G, Leyton L, Párraga M. 2004. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol 82:129-144.
119. Rall SC Jr, Weisgraber KH, Mahley RW. 1982. Human apoli-poprotein E: The complete amino acid sequence. J Biol Chem 257:4171-4178.
120. Ramsey RB, Nicholas HJ. 1972. Brain lipids. Adv Lipid Res 10:143-232.
121. Rao AM, Igbavboa U, Semotuk M, Schroeder F, Wood WG. 1993. Kinetics and size of cholesterol lateral domains in synaptosomal membranes: Modification by sphingomyeli-nase and effects on membrane enzyme activity. Neurochem Int 23:45-52.
122. Rebeck GW. 2004. Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis. J Mol Neurosci 23:219-224.
123. Refolo LM, Pappolla MA, Malester B, La Francois J, Bryant-Thomas T, et al. 2000. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7:321-331.
124. Rip JW, Rupar CA, Ravi K, Carroll KK. 1985. Distribution, metabolism, and function of dolichol and polyprenols. Prog Lipid Res 24:269-309.
125. Roelofsen B. 1982. Phospholipases as tools to study the localization of phospholipids in biological membranes. A critical review. J Toxicol 1(1):87-197.
126. Roheim PS, Carey M, Forte T, Vega GL. 1979. Apolipopro-teins in human cerebrospinal fluid. Proc Natl Acad Sci USA 76:4646-4649.
127. Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, et al. 2002. Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci 22:1679-1689.
128. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, et al. 1993. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
129. Schachter D, Abbott RE, Cogan U, Flamm M. 1983. Lipid fluidity of the individual hemileaflets of human erythrocyte membranes. Ann NYAcad Sci 414:19-28.
130. Schinkel AH. 1997. The physiological function of drug-transporting P-glycoproteins. Semin Cancer Biol 8:161-170.
131. Schroeder F, Frolov AA, Murphy EJ, Atshaves BP, Pu L, et al. 1996. Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking. Proc Soc Exp Biol Med 213:150-177.
132. Schroeder F, Morrison WJ, Gorka C, Wood WG. 1988. Trans-bilayer effects of ethanol on fluidity of brain membrane leaflets. Biochim Biophys Acta 946:85-94.
133. Schroeder F, Nemecz G, Wood WG, Morrot G, Ayraut-Jarrier M, et al. 1991. Transmembrane distribution of sterol in the human erythrocyte. Biochim Biophys Acta 1066:183-192.
134. Shepherd J, Blauw GJ, Murphy MB, Bollen E L EM, Buckley BM, et al. 2002. Pravastatin in elderly at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 360:1623-1630.
135. Simons K, Ikonen E. 2000. How cells handle cholesterol. Science 290:1721-1726.
136. Simons M, Keller P, Destrooper B, Beyreuther K, Dotti CG, et al. 1998. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460-6464.
137. Sipione S, Rigamonti D, Valenza M, Zuccato C, Conti L, et al. 2002. Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet 15:1953-1965.
138. Slotte JP, Bierman EL. 1988. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem J 250:653-658.
139. Sparks DL, Connor DJ, Browne PJ, Lopez JE, Sabbagh MN. 2002. HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advised to use one that crosses the blood-brain barrier. J Nutr Health Aging 6:324-331.
140. Srere PA, Chaikoff IL, Treitman SS, Burstein LS. 1950. The extrahepatic synthesis of cholesterol. J Biol Chem 182:629-634.
141. Subczynski WK, Kusumi A. 2003. Dynamics of raft molecules in the cell and artificial membranes: Approaches by pulse EPR spin labeling and single molecule optical microscopy. Biochim Biophys Acta 1610:231-243.
142. Sun Y, Wu S, Bu G, Onifade MK, Patel SN, et al. 1998. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgen-ic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci 18:3261-3272.
143. Suresh S, Yan Z, Patel RC, Patel YC, Patel SC. 1998. Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. J Neurochem 70:242-251.
144. Teixeira A, Chaverot N, Schröder C, Strosberg AD, Couraud P-O, et al. 1999. Requirement of caveolae microdomains in extracellular signal-regulated kinase and focal adhesion kinase activation induced by endothelin-1 in primary astro-cytes. J Neurochem 72:120-128.
145. Teter B, Finch CE. 2004. Caiban's heritance and the genetics of neuronal aging. Trends Neurosci 27:627-632.
146. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, et al. 2002. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J Neurosci Res 68:331-336.
147. Thiele C, Hannah MJ, Fahrenholz F, Huttner WB. 2000. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2:42-49.
148. Titov VN. 1997. Structure of Apo A-I high density lipopro-teins: A review. Biochemistry (Moscow) 62:3-19.
149. Tong H, Holstein SA, Hohl RJ. 2005. Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells. Anal Biochem 336:51-59.
150. Tosi MR, Bottura G, Lucchi P, Reggiani A, Trinchero A, et al. 2003. Cholesteryl esters in human malignant neoplasms. Int J Mol Med 11:95-98.
151. Turley SD, Dietschy JM. 1997. Regional variation in cholesterol synthesis and low-density lipoprotein transport in the brain of the fetus, newborn, and adult animal. Nutr Metab Cardiovasc Dis 7:195-201.
152. Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, et al. 2005. Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci 25:9932-9939.
153. Vance DE, Van den Bosch H. 2001. Cholesterol in the year 2000. Biochim Biophys Acta 1529:1-8.
154. Vance JE, Hayashi H, Karten B. 2005. Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 16:193-212.
155. Vanier MT, Rousson R, Louisot P. 1983. Chromatofocusing of skin fibroblast sphingomyelinase: Alterations in Niemann-Pick disease type C shared by GM1-gangliosidosis. Clin Chim Acta 130:155-161.
156. Waelsch H, Sperry WM, Stoyanoff VA. 1940. Lipid metabolism in brain during myelination. J Biol Chem 135:297-302.
157. Wassmann S, Laufs U, Bäumer AT, Müller K, Konkol C, et al. 2001. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth cells: Involvement of angiotensin AT1 receptor expression Rac1 GTPase. Mol Pharmacol 59:646-654.
158. Weisgraber KH, Rall SC, Mahley RW. 1981. Human E apo-protein heterogeneity cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256:9077-9083.
159. White F, Nicoll JA, Roses AD, Horsburgh K. 2001. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol Dis 8:611-625.
160. Wolfe LS, Ng Ying Kin NM, Palo J, Bergeron C, Kotila M, et al. 1985. Dolichols are elevated in brain tissue from Alzheimer's disease, but not in urinary sediment from Alzheimer's disease and Down's syndrome. Neurochem Pathol 3:213-221.
161. Wolozin B. 2004. Cholesterol, statins, and dementia. Curr Opin Lipidol 15:667-672.
162. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439-1443.
163. Wood WG, Schroeder F. 1988. Membrane structure in aged humans and animals. Central Nervous System Disorders of Aging: Clinical Intervention and Research. Strong R, Wood WG, Burke WJ, editors. New York: Raven Press; pp. 199-209.
164. Wood WG, Eckert GP, Igbavboa U, Müller WE. 2003. Amyloid β-peptide interactions with membranes and cholesterol: Causes or casualties of Alzheimer's disease. Biochim Biophys Acta 1610:281-290.
165. Wood WG, Gorka C, Schroeder F. 1989a. Acute and chronic effects of ethanol on transbilayer membrane domains. J Neurochem 52:1925-1930.
166. Wood WG, Sun GY, Schroeder F. 1989b. Membrane properties of dolichol in different age groups of mice. Chem Phys Lipids 51:219-226.
167. Wood WG, Gorka C, Williamson LS, Strong R, Sun AY, et al. 1986. Dolichol alters dynamic and static properties of mouse synaptosomal plasma membranes. FEBS Lett 205(1):25-28.
168. Wood WG, Igbavboa U, Eckert GP, Johnson-Anuna LN, Müller WE. 2005. Is hypercholesterolemia a risk factor for Alzheimer's disease? Mol Neurobiol 31:185-192.
169. 2+-ATPase activity, interdigitation, and increases fluidity of brain syn-aptic plasma membranes. Brain Res 683:36-42.
170. Wood WG, Rao AM, Igbavboa U, Semotuk M. 1993. Cholesterol exchange and lateral cholesterol pools in synap-tosomal membranes of pair-fed control and chronic ethanol-treated mice. Alcohol Clin Exp Res 17:345-350.
171. Wood WG, Schroeder F, Avdulov NA, Chochina SV, Igbavboa U. 1999. Recent advances in brain cholesterol dynamics: Transport, domains and Alzheimer's disease. Lipids 34:225-234.
172. Wood WG, Schroeder F, Hogy L, Rao AM, Nemecz G. 1990. Asymmetric distribution of a fluorescent sterol in synaptic plasma membranes: Effects of chronic ethanol consumption. Biochim Biophys Acta 1025:243-246.
173. Wood WG, Schroeder F, Igbavboa U, Avdulov NA, Chochina SV. 2002. Brain membrane cholesterol domains, aging, and amyloid β-peptides. Neurobiol Aging 23:685-694.
174. Wu C, Butz S, Ying Ys, Anderson R G W. 1997. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J Biol Chem 272:3554-3559.
175. Xu Q, Li YH, Cyras C, Sanan DA, Cordell B. 2000. Isolation and characterization of apolipoproteins from murine microglia. J Biol Chem 275:31770-31777.
176. Yamada E. 1955. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1:445-458.
177. Ye S, Huang Y, Mullendorff K, Dong L, Giedt G, et al. 2005. Apolipoprotein (apo) E4 enhances amyloid-β peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target. Proc Natl Acad Sci USA 102:18700-18705.
178. Zachowski A. 1993. Phospholipids in animal eukaryotic membranes: Transverse asymmetry and movement. Biophys J 294:1-14.